EGM Shareholder Presentation
150526_EGM Shareholder Presentation
Second Dog Shows Suppression of Cancer Marker at Days 3 & 7
150519_Second Dog Shows Suppression of Cancer Marker at Days 3 & 7
Reduction of further Cancer Marker confirmed in Human Trial
150511_Reduction of further Cancer Marker confirmed in Human Trial
First Dog Shows Suppression of Cancer Marker
150501_First Dog Shows Suppression of Cancer Marker
Approval of Dose Escalation of PPL-1 in Human Trial
150415_Approval of Dose Escalation of PPL-1 in Human Trial
Modification of Clinical Trial in Dogs
150413_Modification of Clinical Trial in Dogs
PharmAust Broker Roadshow Presentation – April 2015
150401_PharmAust Broker Roadshow Presentation – April 2015
Lyell McEwin Hospital approved to join PharmAust trial
150408_Lyell McEwin Hospital approved to join PharmAust trial
Appendix 4C Quarterly Report & Company Update
150422_Appendix 4C Quarterly Report & Company Update
Joint Patent with Japanese Corporation now published
150331_Joint Patent with Japanese Corporation now published